KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory (2016 - 2022)

TherapeuticsMD (TXMD) has disclosed Inventory for 13 consecutive years, with $6.7 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Inventory fell 8.98% year-over-year to $6.7 million, compared with a TTM value of $6.7 million through Sep 2022, down 8.98%, and an annual FY2021 reading of $7.6 million, down 4.64% over the prior year.
  • Inventory was $6.7 million for Q3 2022 at TherapeuticsMD, up from $6.1 million in the prior quarter.
  • Across five years, Inventory topped out at $14.6 million in Q1 2020 and bottomed at $1.6 million in Q1 2018.
  • Average Inventory over 5 years is $7.3 million, with a median of $7.5 million recorded in 2019.
  • The sharpest move saw Inventory soared 342.89% in 2019, then plummeted 49.71% in 2021.
  • Year by year, Inventory stood at $3.3 million in 2018, then skyrocketed by 262.97% to $11.9 million in 2019, then crashed by 32.61% to $8.0 million in 2020, then fell by 4.64% to $7.6 million in 2021, then fell by 12.08% to $6.7 million in 2022.
  • Business Quant data shows Inventory for TXMD at $6.7 million in Q3 2022, $6.1 million in Q2 2022, and $9.0 million in Q1 2022.